JOHNSON & JOHNSON Retained Earnings 2008-2026 | JNJ
Beta
What is retained earnings?
Retained earnings represent the cumulative net income that has been reinvested in the business rather than distributed as dividends to shareholders.
What is JOHNSON & JOHNSON's current retained earnings?
JOHNSON & JOHNSON (JNJ) annual retained earnings for 2025 was $168.98B, a 8.46% increase from 2024. JOHNSON & JOHNSON retained earnings for the quarter ending March 29, 2026 was $169.16B.
What was JOHNSON & JOHNSON's retained earnings in 2024?
JOHNSON & JOHNSON annual retained earnings for 2024 was $155.79B, a 1.27% increase from 2023.
What was JOHNSON & JOHNSON's retained earnings in 2023?
JOHNSON & JOHNSON annual retained earnings for 2023 was $153.84B, a 25.01% increase from 2022.
What is JOHNSON & JOHNSON's 4-year retained earnings CAGR?
JOHNSON & JOHNSON retained earnings grew at a compound annual growth rate (CAGR) of 10.37% from FY2021 to FY2025, going from $113.89B to $168.98B over 4 years.
Retained Earnings History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+8.8%
FY2019
$110.66B
→
FY2025
$168.98B
081011121314161718192122232425
5 years selected
Retained Earnings History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $168.98B | +8.5% | 10-K |
| FY2024 | $155.79B | +1.3% | 10-K |
| FY2023 | $153.84B | +25.0% | 10-K |
| FY2022 | $123.06B | +8.1% | 10-K |
| FY2021 | $113.89B | +2.9% | 10-K |
| FY2019 | $110.66B | +4.2% | 10-K |
| FY2018 | $106.22B | +4.3% | 10-K |
| FY2017 | $101.79B | -2.0% | 10-K |
| FY2016 | $103.88B | +6.8% | 10-K |
| FY2014 | $97.25B | +8.7% | 10-K |
| FY2013 | $89.49B | +4.1% | 10-K |
| FY2012 | $85.99B | +10.6% | 10-K |
| FY2011 | $77.77B | +10.6% | 10-K |
| FY2010 | $70.31B | +10.9% | 10-K |
| FY2008 | $63.38B | - | 10-K |
Company: JOHNSON & JOHNSONTicker: JNJSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →